ARDX Long Call Strategy

ARDX (Ardelyx, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Ardelyx, Inc. is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of innovative medicines. The company primarily focuses on addressing gastrointestinal (GI) and cardiorenal conditions, serving patients both domestically in the United States and across international markets. Its flagship product candidate is tenapanor. This drug has successfully completed Phase III clinical trials for treating irritable bowel syndrome with constipation (IBS-C) and is also currently in Phase III development to manage hyperphosphatemia (high serum phosphorus) in adult patients with chronic kidney disease (CKD) who are undergoing dialysis. Ardelyx is also advancing other key pipeline assets, including RDX013, a potassium secretagogue designed to combat hyperkalemia (elevated serum potassium), a significant issue for individuals with compromised kidney and/or heart function. Furthermore, the company is in the early stages of developing RDX020, which targets metabolic acidosis, a serious electrolyte disorder frequently seen in CKD patients.

ARDX (Ardelyx, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.37B, a beta of 0.58 versus the broader market, a 52-week range of 3.74-8.4, average daily share volume of 3.8M, a public-listing history dating back to 2014, approximately 395 full-time employees. These structural characteristics shape how ARDX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.58 indicates ARDX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on ARDX?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ARDX snapshot

As of June 29, 2026, spot at $5.16, ATM IV 160.00%, IV rank 39.41%, expected move 45.87%. The long call on ARDX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long call structure on ARDX specifically: ARDX IV at 160.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 45.87% (roughly $2.37 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ARDX expiries trade a higher absolute premium for lower per-day decay. Position sizing on ARDX should anchor to the underlying notional of $5.16 per share and to the trader's directional view on ARDX stock.

ARDX long call setup

The ARDX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ARDX near $5.16, the first option leg uses a $5.16 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ARDX chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ARDX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$5.16N/A

ARDX long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ARDX long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ARDX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ARDX

Long calls on ARDX express a bullish thesis with defined risk; traders use them ahead of ARDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ARDX thesis for this long call

The market-implied 1-standard-deviation range for ARDX extends from approximately $2.79 on the downside to $7.53 on the upside. A ARDX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ARDX IV rank near 39.41% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on ARDX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ARDX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ARDX-specific events.

ARDX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ARDX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ARDX alongside the broader basket even when ARDX-specific fundamentals are unchanged. Long-premium structures like a long call on ARDX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ARDX chain quotes before placing a trade.

Frequently asked questions

What is a long call on ARDX?
A long call on ARDX is the long call strategy applied to ARDX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ARDX stock trading near $5.16, the strikes shown on this page are snapped to the nearest listed ARDX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ARDX long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ARDX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 160.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ARDX long call?
The breakeven for the ARDX long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ARDX market-implied 1-standard-deviation expected move is approximately 45.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ARDX?
Long calls on ARDX express a bullish thesis with defined risk; traders use them ahead of ARDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ARDX implied volatility affect this long call?
ARDX ATM IV is at 160.00% with IV rank near 39.41%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related ARDX analysis